Stocks Health care IPSC
NASDAQ · Health careCentury Therapeutics, Inc. (IPSC)
It posted a net loss of $109.8M. In fiscal 2025 capital spending exceeded operating cash flow by $104.7M. At June 30, 2026 it held $49.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
What Century Therapeutics, Inc. does
Century Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker IPSC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $109.2M | -$9.6M | -$0.14 | -$104.7M |
| 2024 | $6.6M | -$126.6M | -$1.61 | -$110.3M |
| 2023 | $2.2M | -$136.7M | -$2.30 | -$102.1M |
| 2022 | $5.2M | -$130.9M | -$2.96 | -$16.6M |
| 2021 | n/a | -$95.8M | -$3.86 | -$134M |
| 2021 | n/a | -$53.6M | -$9.34 | -$51.1M |
Latest SEC filings
What Century Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 9, 2026
- August 12, 2026
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026
- June 16, 2026
- June 12, 2026
- June 8, 2026Other event 8-K
- May 21, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 13, 2026
Questions about IPSC
What does Century Therapeutics, Inc. do?
Century Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker IPSC.
Is Century Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $109.8M.
When did Century Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 15, 2026.
Similar companies
Follow IPSC
Get an email when Century Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow IPSC: get an email when it filesWhere the numbers come from
Financial figures are the values Century Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.